581上海医药2011年第32卷第12期580上海医药2011年第32卷第12期医药综述[18]CoiffierB,ThieblemontC,vandenNesteE,etal
Long-termoutcomeofpatientsintheLNH-98
5trial,thefirstrandomizedstudycomparingrituximab-CHOPtostandardCHOPchemotherapyinDLBCLpatients:astudybytheGrouped’EtudesdesLymphomesdel’Adulte[J].Blood,2010,116(12):2040-2045
[19]vanMeterME,KimES
Bevacizumab:currentupdatesintreatment[J].CurrOpinOncol,2010,22(6):586-591
[20]DemetriGD,vanOosteromAT,GarrettCR,etal
Efficacyandsafetyofsunitinibinpatientswithadvancedgastrointestinalstromaltumourafterfailureofimatinib:arandomisedcontrolledtrial[J].Lancet,2006,368(9544):1329-1338
[21]AlainR,RobertH,JasonP,etal
Lapatinibversushormonetherapyinpatientswithadvancedrenalcellcarcinoma:arandomizedphaseIIIclinicaltrial[J].JClinOncol,2008,26(14):2285-2291
(收稿日期:2011-07-26)糖皮质激素(glu